ArticleFrontiers in medicine2026
Therapeutic potential of Jatimukuladi Varti Anjana in alkali burn-induced corneal injury and neovascularization in albino rats.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Corneal transparency is maintained by its avascular nature, and disruption following injury can lead to corneal neovascularization (CNV), resulting in visual impairment. Although current treatment such as corticosteroids, NSAIDs, anti-VEGF agents, and surgical interventions are available, their use is often limited by adverse effects, recurrence, and cost. Jatimukuladdiv arti Anjana (JMV), a classical ayurvedic ophthalmic formulation with reported anti-inflammatory and tissue-healing properties, was evaluated for its therapeutic efficacy in an alkali burn-induced CNV model in albino rats. Methods: Eighteen Swiss albino rats (36 eyes) were used. Corneal injury was induced in albino rats using a standardized alkali burn model. Animals were allocated to control, standard treatment, and JMV-treated groups ( Results: JMV treatment was associated with significant improvement in corneal healing, characterized by reduced opacity, neovascularization, vascular enlargement, and corneal haze compared with the untreated control group. Histopathological findings supported these observations, revealing attenuation of inflammatory and fibrotic changes with improved tissue organization and epithelial restoration in treated animals. Discussion: The present study evaluated the therapeutic potential of Jatimukuladi Varti Anjana (JMV) in an experimental model of alkali burn-induced corneal injury and neovascularization in albino rats. The findings demonstrated that JMV significantly improved corneal healing, as evidenced by reduced corneal opacity, neovascularization, vessel size, and corneal haze compared with the untreated control group. Conclusion: JMV demonstrated significant anti-angiogenic and wound-healing potential in alkali-burn-induced CNV. These findings support its potential role as an integrative therapeutic option for corneal neovascularisation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.